The HDAC Inhibitor Market is expected to register a CAGR of 7.8% from 2025 to 2031. The HDAC inhibitor market is witnessing notable growth, driven by increasing research in epigenetics, rising cancer prevalence, and expanding applications of histone deacetylase (HDAC) inhibitors in oncology and other therapeutic areas. HDAC inhibitors are a class of compounds that interfere with the...

The healthcare contract manufacturing organization (CMO) market is experiencing significant growth, driven by the increasing demand for outsourced manufacturing services in the pharmaceutical, biotechnology, and medical device industries. CMOs provide vital services such as drug formulation, production, packaging, and quality control, allowing companies to focus on their core competencies while...